Am. Harrison et al., GASTRIC PH CONTROL IN CRITICALLY ILL CHILDREN RECEIVING INTRAVENOUS RANITIDINE, Critical care medicine, 26(8), 1998, pp. 1433-1436
Objective: To determine whether the dose of ranitidine recommended in
commonly used pediatric drug dosage handbooks (2 to 4 mg/kg/day iv) re
sults in successful gastric pH control (pH of greater than or equal to
4) in critically ill children, Design: Prospective sample. Setting: P
ediatric intensive care unit in a tertiary care children's hospital,Pa
tients: Fifty consecutive patients who received greater than or equal
to 24 hrs of scheduled intermittent intravenous ranitidine for stress
ulcer prophylaxis were enrolled in the study. Patients with renal or h
epatic dysfunction and those who received enteral nutrition through th
e nasogastric tube were excluded from enrollment. Intervention: Gastri
c pH was determined at the end of the ranitidine dosing interval, 1 hr
after the dose, and at the midpoint between doses. Alt pH measurement
s were made from a sample of nasogastric aspirate, using pH sensitive
paper. Gastric pH control with ranitidine was considered unsuccessful
(poorly controlled) if the pH was <4 for any of the three measurements
, Measurements and Main Results: Forty five patients (median age 36 mo
s; range 2 wks to 264 mos) were included in the analysis, Eighty-two p
ercent of the patients were mechanically ventilated, 16% were pharmaco
logically paralyzed, 18% required vasoactive infusions, 36% were nouri
shed via transpyloric feeding tubes, and 7% received total parenteral
nutrition. Gastric pH was poorly controlled in 36% of patients. Among
these patients, the pH at the end of the dosing interval was significa
ntly lower than the pH measured at 1 hr or at the midpoint between dos
es (p < .05). Seventy-one percent of patients who received <3 mg/kg/da
y of ranitidine had poor gastric pH control as compared with 19% who r
eceived a minimum of 3 mg/kg/day (p < .05). Poor control of gastric pH
was not associated with feeding, intubation status, presence of pharm
acologic paralysis, use of vasoactive infusions, or age (p > .05). Con
clusions: The minimum ranitidine dose recommended in commonly used ped
iatric drug references resulted in unsuccessful gastric pH control in
a high percentage of pediatric intensive care unit patients. Criticall
y ill children with normal renal and hepatic function should be treate
d with a minimum 3 mg/kg/day of intravenous ranitidine and the dose sh
ould be titrated to a gastric pH of greater than or equal to 4.